Insights Center
Thought leadership, news, events — you will find them all here, right at your fingertips. We’ve consolidated the firm’s most popular content in one, easy to search location. Enter a key word or phrase to find pertinent blog posts, articles, press releases, and upcoming events.
Mintz Viewpoints
Showing 9481 - 9488 of 11617 results
On the Tenth Day of Privacy, OCR Gave to Me.....
December 22, 2014| Blog| Viewpoint
Municipal Bond Interest Paid By a Bond Insurer After an Issuer's Bankruptcy Discharge Can Remain Tax-Exempt
December 22, 2014| Blog| Viewpoint
CAFC Delivers Another Decision on Patentability of Myriad Patents
December 19, 2014| Alert| Viewpoint
Trademark Licensees May Be Protected in a Licensor’s Bankruptcy Even After a “Free and Clear” Sale
December 19, 2014| Advisory| Viewpoint
Registration Begins for American Telemedicine Association’s New Accreditation of Online Medical Services
December 19, 2014| Blog| Viewpoint
On the Ninth Day of Privacy, my true love gave to me....
December 19, 2014| Blog| Viewpoint
News & Press Releases
Mintz Announces New Members
December 20, 2024
Mintz announces the election of eight attorneys to Members, effective January 1, 2025. The newly promoted Members join the ranks of the firm’s growing membership, including six new lateral Members who joined the firm in 2024.
Mintz represented the US Department of Energy (DoE) Loan Programs Office (LPO) in the closing of a $1.45 billion loan guarantee to Hanwha Q Cells Georgia, Inc. (QCells), a leading North American crystalline silicon solar manufacturer.
Dealmaking Dormant No More
December 17, 2024
International Chair of Life Sciences Cheryl Reicin recently participated in a Q&A with Pharmaceutical Executive in which she discusses the ongoing effects of the pandemic on dealmaking trends in the pharmaceutical industry. Cheryl specifically mentions how M&A activity began to rise again in 2024 after slowing in 2023, and that she expects acquisitions to continue picking up in 2025.